Low‐Dose Cisplatin‐Based Radiation Therapy for Refractory Recurrent Respiratory Papillomatosis

• Published in: The Laryngoscope Vol. 134; no. 5; pp. 2335 - 2337
• Main Authors: Takatsuki, Eri, Kono, Takeyuki, Tomisato, Shuta, Ozawa, Hiroyuki
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.05.2024
• Subjects: de‐escalated radiotherapy; low‐dose cisplatin; recurrent respiratory papillomatosis; trachea; recurrent respiratory papillomatosis; trachea; de‐escalated radiotherapy; low‐dose cisplatin
• ISSN: 0023-852X; 1531-4995
• DOI: 10.1002/lary.31096

Recurrent respiratory papilloma (RRP) often presents multiple lesions in the respiratory tract and sometimes becomes fatal because of severe airway obstruction. We report the case of a 69‐year‐old woman who had juvenile‐onset RRP in the trachea that was refractory to surgical treatment, and complete remission was achieved by low‐dose cisplatin combined with de‐escalated radiotherapy without any side effects. This case report is the first to illustrate the data on low‐dose cisplatin for refractory benign RRP, and our experience reinforces the opinion that low‐dose cisplatin combined with de‐escalated radiotherapy can be an effective and safe treatment alternative for uncontrollable and lethal RRP. Laryngoscope, 134:2335–2337, 2024 This is a case report of a patient with refractory tracheal recurrent respiratory papilloma (RRP) who underwent low‐dose cisplatin combined with de‐escalated radiotherapy. RRP effectively disappeared and achieved complete remission without any adverse events, suggesting low‐dose cisplatin is considered an effective and safe treatment alternative for RRP.